HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

4- (4- fluorophenyl)- 2- (4- hydroxyphenyl)- 5- (4- pyridyl)imidazole

structure given in first source; inhibits p38 MAP kinase
Also Known As:
SB 202190; SB-202190; SB202190
Networked: 65 relevant articles (3 outcomes, 3 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Simone, Cristiano: 2 articles (12/2012 - 09/2007)
2. Browne, Andrew: 1 article (10/2015)
3. Rauner, Martina: 1 article (10/2015)
4. Hötzel, Josefa: 1 article (10/2015)
5. Hofbauer, Lorenz C: 1 article (10/2015)
6. Rachner, Tilman D: 1 article (10/2015)
7. Göbel, Andy: 1 article (10/2015)
8. Kang, Tae-Cheon: 1 article (09/2015)
9. Ko, Ah-Reum: 1 article (09/2015)
10. Grisanti, Salvatore: 1 article (02/2015)

Related Diseases

1. Memory Disorders (Memory Loss)
2. Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
3. Sunburn
4. Chondrosarcoma
5. Infection

Related Drugs and Biologics

1. p38 Mitogen-Activated Protein Kinases
2. Phosphotransferases (Kinase)
3. PD 169316
4. PD 98059
5. Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)
6. Protein Kinase Inhibitors
7. Protein Kinases (Protein Kinase)
8. U 0126 (UO 126)
9. SB 203580
10. anthra(1,9-cd)pyrazol-6(2H)-one

Related Therapies and Procedures

1. Filtering Surgery
2. Ligation
3. Debridement